Tag: Chronic weight management

In clinical trials, many participants on Contrave, combined with a healthy diet and exercise, experienced significant weight loss and continued treatment long-term. The question of **how long can you stay on Contrave?** is determined by your individual response and overall health goals, with the duration guided by a healthcare provider.

In clinical trials, patients taking Zepbound (tirzepatide) lost an average of up to 20.9% of their body weight over 72 weeks [1.6.2]. A common question for users is, 'Is it better to take Zepbound in the morning or at night?'

Clinical trials show that, when combined with diet and exercise, patients taking Contrave typically lose between 5% and 10% of their initial body weight over a period of 56 weeks. This means the number of pounds can vary significantly depending on your starting weight and how your body responds to the medication.

Phentermine is a stimulant appetite suppressant approved only for short-term use, carrying risks like increased heart rate and blood pressure. For many, the question is, what's safer than phentermine? Fortunately, several modern, long-term options exist, offering effective weight management with different safety profiles and lower potential for dependence.

While the appetite suppressant phentermine has been used for weight loss since 1959, its use is limited to short-term treatment of a few weeks. Today, the concept of a “new version of phentermine” refers to a range of modern, often more powerful and long-term, medication options that have emerged for chronic weight management.

In 2024, a study in the *New England Journal of Medicine* showed that tirzepatide led to greater weight loss outcomes compared to semaglutide in head-to-head trials. This sheds light on the "M drug," Mounjaro, which contains tirzepatide but is approved for Type 2 diabetes, and its dedicated weight-loss version, Zepbound.